Magnesiumsulfat heptahydrat 99.0-100.5%, kristaller USP, Multi-Compendial, J.T.Baker®
Leverantör: Avantor
Synonyms:
sulphuric acid magnesium salt heptahydrate, Epsom salt, Bitter salt
2504-01EA
1250
SEK
2504-01
2504-05
2504-07
2504-08
Magnesiumsulfat heptahydrat 99.0-100.5%, kristaller USP, Multi-Compendial, J.T.Baker®
Magnesiumsulfat heptahydrat
- GMP manufactured product
|
Formel:
MgSO₄·7H₂O MW: 246,48 g/mol Smältpunkt: 1124 °C Densitet: 1,67 g/cm³ Storage Temperature: Omgivande |
MDL Number:
MFCD00149785 CAS nummer: 10034-99-8 EINECS: 231-298-2 Merck Index: 13,05715 |
Specifikation testresultat
| GMP Manufactured Product | Passes Test |
| Meets B.P. Chemical Specifications | 5.0 - 9.2 |
| Meets E.P. Chemical Specifications | 40.0 - 52.0% |
| Meets U.S.P Requirements | ≤0.014% |
| Preserve in well-closed containers. | ≤0.5 ppm |
| CAUTION: For Manufacturing, processing or repackaging | ≤0.003% |
| Bulk Pharmaceutical Chemical | 99.0 - 100.5% |
| USP - Identification | Passes Test |
| USP - pH (1 in 20) | 5.0 - 9.2 |
| USP - Loss on Ignition | 40.0 - 52.0 % |
| USP - Chloride (Cl) | ≤ 0.014 % |
| USP - Iron (Fe) | ≤ 0.5 ppm |
| USP - Selenium (Se) | ≤ 0.003 % |
| USP - Assay (MgSO₄) (anhydrous basis) | 99.0 - 100.5 % |
| USP - Endotoxin Concentration (EU/g) | ≤ 2.5 |
| EP/BP - Identification A | Passes Test |
| EP/BP - Identification B | Passes Test |
| EP/BP - Appearance of Solution | Passes Test |
| EP/BP - Acidity or Alkalinity | Passes Test |
| EP/BP - Chloride (Cl) | ≤ 300 ppm |
| EP/BP - Arsenic (As) | ≤ 2 ppm |
| EP/BP - Iron (Fe) | ≤ 20 ppm |
| EP/BP - Loss on Drying | 48.0 - 52.0 % |
| EP/BP - Assay (MgSO₄) (anhydrous basis) | 99.0 - 100.5 % |
| Solution Test | Passes Test |
| No Class 1,2,3 or other solvents are used or produced in the | |
| manufacturing or purification of the product. | |
| Metallic Residues: No metal catalysts or metal reagents, as defined by | |
| EMA Guideline EMEA/CHMP/SWP/4446/2000 , are used in the production of | |
| this material. | |
| This product is intended for use in preparing parenteral and | |
| nonparenteral dosage forms. |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...